The SOPHIA study retrospectively investigated the first-in-man safety and efficacy in 6 patients with stress urinary incontinence who received the UroActive TM device. Results from the primary ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...